<DOC>
	<DOCNO>NCT00407589</DOCNO>
	<brief_summary>This multi-center , open-label , single dose/multiple dose , pharmacokinetic study participant bacterial conjunctivitis . The purpose study determine extent systemic exposure BOL-303224-A follow single multiple topical administration BOL-303224-A participant suspect bacterial conjunctivitis .</brief_summary>
	<brief_title>Systemic Pharmacokinetics BOL-303224-A</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Bacterial</mesh_term>
	<mesh_term>7- ( 3-aminohexahydro-1H-azepin-1-yl ) -8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>must least 18 year age , race must clinical diagnosis acute bacterial conjunctivitis exhibit purulent conjunctival discharge redness eye woman childbearing potential must utilize reliable contraceptive method negative pregnancy test Pregnant nursing woman know hypersensitivity fluoroquinolones ingredient study medication use antibiotic within 72 hour enrollment participation ophthalmic drug devise research study within 30 day prior entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>